Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06487533 · ClinicalTrials.gov registry record
Sensing Physiological Symptoms of Opioid Withdrawal and Cravings in Patients With Opioid Use Disorder
A clinical trial of Opioid Use Disorder and Opioid Withdrawal, sponsored by Spark Biomedical.
- Recruiting
- Registry status
- 20
- Enrollment target
- 2
- Study locations
NCT06487533 is a study of Opioid Use Disorder and Opioid Withdrawal that is actively recruiting participants, run by Spark Biomedical. The registered enrollment target is 20 participants, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT06487533, a study of Opioid Use Disorder and Opioid Withdrawal, is actively recruiting participants, sponsored by Spark Biomedical.
- RECRUITING
- Registry status
- 20 participants
- Enrollment target
- 2
- Study locations
Study Summary
The primary objective of this trial is to measure changes in physiologic signals to quantify the status of the autonomic nervous system during opioid withdrawal and cravings.
Conditions Studied
Interventions
- DEVICE EmbracePlus Smartwatch
- DEVICE Corti Sensor
Study Locations (2)
Minnesota
- Hazelden Betty Ford Foundation - Center City
Ohio
- Battelle Memorial Institute - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2025-02-19 |
| Est. Completion | 2026-05-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06487533
The ClinicalTrials.gov registry entry for NCT06487533 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (100% lower). The listed sponsor is Spark Biomedical, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Opioid Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which EmbracePlus Smartwatch is the first listed.
NCT06487533 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Minnesota, Ohio.
Frequently Asked Questions
What is clinical trial NCT06487533 about?
NCT06487533 is a clinical study titled "Sensing Physiological Symptoms of Opioid Withdrawal and Cravings in Patients With Opioid Use Disorder". The primary objective of this trial is to measure changes in physiologic signals to quantify the status of the autonomic nervous system during opioid withdrawal and cravings.
What is the current status of trial NCT06487533?
This trial is currently recruiting. The enrollment target is 20 participants. The study started on 2025-02-19. Estimated completion is 2026-05-31.
What conditions does trial NCT06487533 study?
This clinical trial studies the following conditions: Opioid Use Disorder, Opioid Withdrawal.
What interventions are being tested in trial NCT06487533?
The interventions under investigation include: EmbracePlus Smartwatch (DEVICE), Corti Sensor (DEVICE).
Who is sponsoring clinical trial NCT06487533?
This trial is sponsored by Spark Biomedical, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06487533 being conducted?
This trial has 2 study locations across Minnesota, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Sustaining Recovery for People on Opioid Agonist Treatment With Conversational Agents
RECRUITING · NA
-
Development of an mHealth Behavioral Sleep Medicine Intervention for Use During Medication Assisted Treatment for MOUD
RECRUITING · NA
-
Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders
RECRUITING · Phase 2
-
Systems Analysis and Improvement to Optimize Opioid Use Disorder Care Quality and Continuity for Patients Exiting Jail
RECRUITING · NA
-
Focused Ultrasound for the Complex Patient
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.